Buscar
Mostrando ítems 11-16 de 16
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
(Open Forum Infectious Diseases, 2019-03)
Background. Little is known about the influence of ongoing barriers to care in the persistence of hepatitis C virus (HCV) viremia after treatment with direct-acting antivirals (DAAs) among people living with human ...
Gene editing for HIV cure at the edge
(AIDS Reviews, 2019-01)
Whereas advances in antiretroviral therapy and its widespread use are providing huge benefits in terms of prventing new HIV transmissions to uninfected individuals as well as halting disease progression in patients, the ...
Occult hepatitis B and HIV infection
(European Journal of Gastroenterology & Hepatology, 2019-11)
Introduction Occult hepatitis B virus (HBV) infection, so-called occult B infection (OBI), is defined by the recognition of HBV-DNA in the absence of serum hepatitis B surface antigen (HBsAg). The HBV-DNA genome in OBI is ...
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
(AIDS, 2019-11-15)
Background: Whereas HIV-1 has spread globally, HIV-2 is mainly found in West Africa where dual HIV-1/HIV-2 coinfection is nowadays uncommon. Herein, we report the rate, main characteristics, and treatment outcomes of all ...
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
(Journal of Hepatology, 2019-08)
In October 2018 a large number of international experts with complementary expertise came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). The objectives of the workshop were ...
HTLV testing of solid organ transplant donors
(Clinical Transplantation, 2019)
Carta al editor